We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
-0.66%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$694M
AUM Growth
-$235M
(-25%)
Cap. Flow
-$209M
Cap. Flow
% of AUM
-30.05%
Top 10 Holdings %
Top 10 Hldgs %
4.41%
Holding
1,236
New
502
Increased
176
Reduced
298
Closed
257
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
+$2.36M |
| 2 |
Collegium Pharmaceutical
COLL
|
+$2.32M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$2.29M |
| 4 |
HSII
Heidrick & Struggles
HSII
|
+$2.25M |
| 5 |
HTCH
HUTCHINSON TECHNOLOGY INC
HTCH
|
+$2.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emergent Biosolutions
EBS
|
+$5.99M |
| 2 |
Commercial Metals
CMC
|
+$5.95M |
| 3 |
Benchmark Electronics
BHE
|
+$5.84M |
| 4 |
Upbound Group
UPBD
|
+$5.71M |
| 5 |
FreightCar America
RAIL
|
+$5.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.04% |
| 2 | Industrials | 15.17% |
| 3 | Technology | 12.86% |
| 4 | Consumer Discretionary | 12.11% |
| 5 | Financials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PERY
226
DELISTED
Perry Ellis International Inc
PERY
| $1.09M | 0.16% |
59,205
-237,560
| -80% | -$4.34M |
|
227
Enviri
NVRI
$621M
| $1.09M | 0.16% |
199,753
+77,763
| +64% | +$449K |
|
228
Telephone and Data Systems
TDS
$3.91B
| $1.09M | 0.16% |
+36,090
| New | +$910K |
|
|
CSFL
229
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $1.08M | 0.16% |
72,771
+36,777
| +102% | +$530K |
|
230
Cabot Corp
CBT
$4.65B
| $1.08M | 0.16% |
22,336
-46,253
| -67% | -$1.99M |
|
231
Amkor Technology
AMKR
$16.1B
| $1.08M | 0.16% |
182,880
-333,575
| -65% | -$1.81M |
|
232
Regis Corp
RGS
$69.9M
| $1.08M | 0.16% |
3,547
-731
| -17% | -$212K |
|
|
QADA
233
DELISTED
QAD Inc.
QADA
| $1.07M | 0.15% |
50,530
+30,980
| +158% | +$598K |
|
|
MYCC
234
DELISTED
ClubCorp Holdings, Inc.
MYCC
| $1.07M | 0.15% |
76,359
-50,145
| -40% | -$662K |
|
|
FARO
235
DELISTED
Faro Technologies
FARO
| $1.07M | 0.15% |
+33,160
| New | +$927K |
|
236
Kaiser Aluminum
KALU
$2.67B
| $1.06M | 0.15% |
12,560
-5,832
| -32% | -$458K |
|
|
FTD
237
DELISTED
FTD Companies, Inc. Common Stock
FTD
| $1.06M | 0.15% |
+40,428
| New | +$979K |
|
238
Insteel Industries
IIIN
$633M
| $1.06M | 0.15% |
34,685
+8,195
| +31% | +$205K |
|
|
SRNE
239
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $1.05M | 0.15% |
196,071
+179,024
| +1,050% | +$1.04M |
|
|
CUNB
240
DELISTED
CU Bancorp
CUNB
| $1.05M | 0.15% |
+49,635
| New | +$1.11M |
|
241
Horizon Bancorp
HBNC
$1.03B
| $1.05M | 0.15% |
95,513
-6,552
| -6% | -$72.6K |
|
242
Acco Brands
ACCO
$369M
| $1.04M | 0.15% |
116,260
+83,158
| +251% | +$582K |
|
243
Cohu
COHU
$2.39B
| $1.04M | 0.15% |
87,907
-96,192
| -52% | -$1.12M |
|
244
Manitowoc
MTW
$516M
| $1.04M | 0.15% |
+60,235
| New | +$875K |
|
|
ESIO
245
DELISTED
Electro Scientific Industries
ESIO
| $1.04M | 0.15% |
+145,413
| New | +$943K |
|
246
Albany International
AIN
$2.14B
| $1.03M | 0.15% |
27,309
+15,309
| +128% | +$539K |
|
|
HTWR
247
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $1.02M | 0.15% |
+32,616
| New | +$1.1M |
|
|
CHMA
248
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $1.02M | 0.15% |
+111,842
| New | +$1.21M |
|
|
ARC
249
DELISTED
ARC Document Solutions, Inc.
ARC
| $1.02M | 0.15% |
227,368
+205,533
| +941% | +$770K |
|
250
Allient
ALNT
$1.47B
| $1.02M | 0.15% |
85,142
-255,817
| -75% | -$3.22M |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q1 2016 Portfolio in Review
As of Q1 2016, TFS Capital held 1,236 positions worth $694M, down 25% from $929M the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.
TFS Capital withdrew a net $209M in Q1 2016, closing 257 positions and reducing 298 holdings. Its most notable exit was Benchmark Electronics, an estimated $5.84M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 22% a quarter earlier, followed by Industrials and Technology.
Against the trend, TFS Capital opened a new position in Collegium Pharmaceutical worth $2.31M.
- TFS Capital's largest Q1 2016 buy was Collegium Pharmaceutical: 127,568 shares worth $2.31M.
- TFS Capital added most to Infinity Pharmaceuticals, Inc. in Q1 2016, an estimated $2.36M increase.
- TFS Capital's biggest Q1 2016 reduction was Emergent Biosolutions, cutting an estimated $5.99M.
- TFS Capital fully exited Benchmark Electronics in Q1 2016, selling an estimated $5.84M.
- TFS Capital's ten largest holdings make up 4.4% of its $694M portfolio in Q1 2016.
- TFS Capital opened 502 new positions and closed 257 in Q1 2016.
- TFS Capital's portfolio value fell 25% quarter-over-quarter to $694M.
Based on TFS Capital's 13F filing for Q1 2016, filed 10 May 2016.